BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shen SG, Zhang D, Hu HT, Li JH, Wang Z, Ma QY. Effects of α-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitroWorld J Gastroenterol 2008; 14(15): 2358-2363 [PMID: 18416462 DOI: 10.3748/wjg.14.2358]
URL: https://www.wjgnet.com/1007-9327/full/v14/i15/2358.htm
Number Citing Articles
1
Hong-bo Huan, Xu-dong Wen, Xue-jiao Chen, Lin Wu, Li-li Wu, Liang Zhang, Da-peng Yang, Xia Zhang, Ping Bie, Cheng Qian, Feng Xia. Sympathetic nervous system promotes hepatocarcinogenesis by modulating inflammation through activation of alpha1-adrenergic receptors of Kupffer cellsBrain, Behavior, and Immunity 2017; 59: 118 doi: 10.1016/j.bbi.2016.08.016
2
Yani Zhao, Yan Zhang, Yao Li, Min Yang, Jiani Yuan, Yu Cao, Lu Xu, Xuexinyu Ma, Sisong Lin, Junming An, Siwang Wang. Yohimbine hydrochloride inhibits benign prostatic hyperplasia by downregulating steroid 5α-reductase type 2European Journal of Pharmacology 2021; 908: 174334 doi: 10.1016/j.ejphar.2021.174334
3
Heng-tong Hu, Qing-yong Ma, Dong Zhang, Su-gang Shen, Liang Han, Ya-dong Ma, Ruo-fei Li, Ke-ping Xie. HIF-1α links β-adrenoceptor agonists and pancreatic cancer cells under normoxic conditionActa Pharmacologica Sinica 2010; 31(1): 102 doi: 10.1038/aps.2009.181
4
Jouhyun Jeon, Satra Nim, Joan Teyra, Alessandro Datti, Jeffrey L Wrana, Sachdev S Sidhu, Jason Moffat, Philip M Kim. A systematic approach to identify novel cancer drug targets using machine learning, inhibitor design and high-throughput screeningGenome Medicine 2014; 6(7) doi: 10.1186/s13073-014-0057-7
5
Marisa Coelho, Cátia Soares-Silva, Daniela Brandão, Franca Marino, Marco Cosentino, Laura Ribeiro. β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectivesJournal of Cancer Research and Clinical Oncology 2017; 143(2): 275 doi: 10.1007/s00432-016-2278-1
6
Weina Wang, Xin Guo, Huiwen Dan. <p>α2A-Adrenergic Receptor Inhibits the Progression of Cervical Cancer Through Blocking PI3K/AKT/mTOR Pathway</p>OncoTargets and Therapy 2020; : 10535 doi: 10.2147/OTT.S264409
7
Han Yang, Michal Poznik, Shaojian Tang, Peng Xue, Lidong Du, Chenlu Liu, Xiaochuan Chen, Jason J. Chruma. Synthesis of Conformationally Liberated Yohimbine Analogues and Evaluation of Cytotoxic ActivityACS Omega 2021; 6(29): 19291 doi: 10.1021/acsomega.1c02784
8
Mallory Batty, Rachel Pugh, Ilampirai Rathinam, Joshua Simmonds, Edwin Walker, Amanda Forbes, Shailendra Anoopkumar-Dukie, Catherine McDermott, Briohny Spencer, David Christie, Russ Chess-Williams. The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other CancersInternational Journal of Molecular Sciences 2016; 17(8): 1339 doi: 10.3390/ijms17081339
9
Rajagopal Anitha, Rajakannu Subashini, Gomathi Kannayiram, Dasararaju Gayathri. Chronic Inflammatory-Modulating Potential of Cassia auriculata with Proinflammatory Cytokine IL-1beta and Its Anticancer Effect on Lung Cancer Cell LineAnti-Cancer Agents in Medicinal Chemistry 2021; 21(3): 343 doi: 10.2174/1871520620666200811111114
10
Azar Ramezanpour, Kazem Karami, Mahshid Kharaziha, Mostafa Zakariazadeh, Janusz Lipkowski, Azar Shahpiri, Negar Azizi, Mansoor Namazian. A mononuclear PdII complex with Naphcon; crystal structure, experimental and computational studies of the interaction with DNA/BSA and evaluation of anticancer activityPolyhedron 2021; 206: 115333 doi: 10.1016/j.poly.2021.115333
11
Jing Dong, Ji Che, Yuanyuan Wu, Yixu Deng, Xuliang Jiang, Zhiyong He, Jun Zhang. Dexmedetomidine promotes colorectal cancer progression via Piwil2 signalingCellular Oncology 2024;  doi: 10.1007/s13402-024-00944-8
12
Ada María Herrera-García, María Jesús Domínguez-Luis, María Arce-Franco, Estefanía Armas-González, Diego Álvarez de La Rosa, José David Machado, Martina K. Pec, Manuel Feria, Olga Barreiro, Francisco Sánchez-Madrid, Federico Díaz-González. Prevention of Neutrophil Extravasation by α2-Adrenoceptor–Mediated Endothelial StabilizationThe Journal of Immunology 2014; 193(6): 3023 doi: 10.4049/jimmunol.1400255
13
Jennifer L. Fisher, Elizabeth J. Wilk, Vishal H. Oza, Sam E. Gary, Timothy C. Howton, Victoria L. Flanary, Amanda D. Clark, Anita B. Hjelmeland, Brittany N. Lasseigne. Signature reversion of three disease‐associated gene signatures prioritizes cancer drug repurposing candidatesFEBS Open Bio 2024;  doi: 10.1002/2211-5463.13796
14
Yang Liu, Xiaochen Yu, Junling Zhuang. Epinephrine Stimulates Cell Proliferation and Induces Chemoresistance in Myeloma Cells through the β-Adrenoreceptor in vitroActa Haematologica 2017; 138(2): 103 doi: 10.1159/000478517
15
Konstantinos N Tzirogiannis, Kalliopi T Kourentzi, Sofia Zyga, Vassiliki Papalimneou, Maria Tsironi, Agni D Grypioti, Ioannis Protopsaltis, Dimitrios Panidis, Georgios I Panoutsopoulos. Effect of 5-HT7receptor blockade on liver regeneration after 60-70% partial hepatectomyBMC Gastroenterology 2014; 14(1) doi: 10.1186/s12876-014-0201-2
16
Perioperative Effects of Surgery, Anesthesia and Analgesics Associated with Cancer Progression: A Review Journal of Cancer Research Updates 2018; 7(1): 1 doi: 10.6000/1929-2279.2018.07.01.1
17
Bina Raju, Salah O. Ibrahim. Pathophysiology of oral cancer in experimental animal models: a review with focus on the role of sympathetic nervesJournal of Oral Pathology & Medicine 2011; 40(1): 1 doi: 10.1111/j.1600-0714.2010.00928.x
18
Mary F. McGuire. Pancreatic Cancer: Insights from Counterterrorism TheoriesDecision Analysis 2014; 11(4): 265 doi: 10.1287/deca.2014.0301
19
Hannah P. Priyanka, Uday P. Pratap, Rahul S. Nair, Ramasamy Vasantharekha, Srinivasan ThyagaRajan. Estrogen-receptor status determines differential regulation of α1- and α2-adrenoceptor-mediated cell survival, angiogenesis, and intracellular signaling responses in breast cancer cell linesMedical Oncology 2024; 41(5) doi: 10.1007/s12032-024-02322-8
20
M Pérez-Sayáns, JM Somoza-Martín, F Barros-Angueira, P Gayoso-Diz, EM Otero-Rey, JM Gándra-Rey, A García-García. Activity of β2-adrenergic receptor in oral squamous cell carcinoma is mediated by overexpression of the ADRBK2 gene: a pilot studyBiotechnic & Histochemistry 2012; 87(3): 179 doi: 10.3109/10520295.2011.592151
21
Jude A. Oben, Trusha Patel, Angelina Mouralidarane, Ann Maj Samuelsson, Phillippa Matthews, Joaquim Pombo, Maelle Morgan, Chad Mckee, Junpei Soeda, Marco Novelli, Lucilla Poston, Paul Taylor. Maternal obesity programmes offspring development of non-alcoholic fatty pancreas diseaseBiochemical and Biophysical Research Communications 2010; 394(1): 24 doi: 10.1016/j.bbrc.2010.02.057
22
Anik Banik, Sheikh Rashel Ahmed, Emran Hossain Sajib, Anamika Deb, Shiuly Sinha, Kazi Faizul Azim. Identification of potential inhibitory analogs of metastasis tumor antigens (MTAs) using bioactive compounds: revealing therapeutic option to prevent malignancyMolecular Diversity 2022; 26(5): 2473 doi: 10.1007/s11030-021-10345-w
23
Hermann A.M. Mucke. Drug Repurposing Patent Applications October: December 2021ASSAY and Drug Development Technologies 2022; 20(2): 95 doi: 10.1089/adt.2022.002
24
Chih-Wei Chiu, Cheng-Ying Hsieh, Chih-Hao Yang, Jie-Heng Tsai, Shih-Yi Huang, Joen-Rong Sheu. Yohimbine, an α2-Adrenoceptor Antagonist, Suppresses PDGF-BB-Stimulated Vascular Smooth Muscle Cell Proliferation by Downregulating the PLCγ1 Signaling PathwayInternational Journal of Molecular Sciences 2022; 23(14): 8049 doi: 10.3390/ijms23148049
25
Adel M. Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, Mehboob Hoque, Sajjad Karim, Ibtessam M.R. Hussain, Shams Tabrez, Arpita Roy. Identification of Potential Poly (ADP-Ribose) Polymerase-1 Inhibitors Derived from Rauwolfia serpentina: Possible Implication in Cancer TherapyEvidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/3787162
26
Andres Missair, Juan Pablo Cata, Gina Votta-Velis, Mark Johnson, Alain Borgeat, Mohammed Tiouririne, Vijay Gottumukkala, Donal Buggy, Ricardo Vallejo, Esther Benedetti de Marrero, Dan Sessler, Marc A Huntoon, Jose De Andres, Oscar De Leon Casasola. Impact of perioperative pain management on cancer recurrence: an ASRA/ESRA special articleRegional Anesthesia & Pain Medicine 2019; 44(1): 13 doi: 10.1136/rapm-2018-000001
27
Nasimudeen R. Jabir, Chelapram K. Firoz, Torki A. Zughaibi, Mohammed Abdullah Alsaadi, Adel M. Abuzenadah, Ahmed Ibrahim Al-Asmari, Ahdab Alsaieedi, Bakrudeen Ali Ahmed, Arun Kumar Ramu, Shams Tabrez. A literature perspective on the pharmacological applications of yohimbineAnnals of Medicine 2022; 54(1): 2849 doi: 10.1080/07853890.2022.2131330
28
Adel M. Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, Mehboob Hoque, Sajjad Karim, Ibtessam M. R. Hussain, Shams Tabrez, Arpita Roy. Elucidating Antiangiogenic Potential of Rauwolfia serpentina: VEGFR-2 Targeting-Based Molecular Docking StudyEvidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/6224666
29
Nasimudeen R. Jabir, Mohd Shahnawaz Khan, Nouf Omar Alafaleq, Huma Naz, Bakrudeen Ali Ahmed. Anticancer potential of yohimbine in drug-resistant oral cancer KB-ChR-8–5 cellsMolecular Biology Reports 2022; 49(10): 9565 doi: 10.1007/s11033-022-07847-7
30
Ting Fu, Xiaofeng Qin, Yining Ma, Xinyue Yuan, Siyun Wu, Xiyun Ye, Yongyan Dang. Yohimbine hydrochloride inhibits skin melanin synthesis by regulating wnt/β-catenin and p38/MAPK signal pathwaysJournal of Dermatological Science 2022; 107(1): 17 doi: 10.1016/j.jdermsci.2022.06.005